| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 68,8 k € | -5.4% | 72,7 k € | -23.9% | 95,6 k € | -20.3% | 119,8 k € | +3.2% | 116,2 k € | +1.8% | 114,1 k € | +643.9% | 15,3 k € | +36.1% | 11,3 k € | -43.8% | 20,0 k € | +472.4% | -5,4 k € | +64.8% | -15,3 k € | |
| EBITDA | 68,4 k € | -3.7% | 71,1 k € | -24.4% | 94,0 k € | -20.5% | 118,3 k € | +2.1% | 115,8 k € | +4.4% | 110,9 k € | +640.7% | 15,0 k € | +59.8% | 9,4 k € | -52.4% | 19,7 k € | +340.3% | -8,2 k € | +86.9% | -62,7 k € | |
| Operating profit | 92,6 k € | -23.8% | 121,5 k € | +41.6% | 85,8 k € | +287.8% | -45,7 k € | -149.7% | 91,9 k € | +6.1% | 86,6 k € | +580.0% | 12,7 k € | +49.8% | 8,5 k € | -17.9% | 10,4 k € | +144.1% | -23,5 k € | +69.9% | -77,8 k € | |
| Profit/loss | 76,1 k € | +2293.0% | -3,5 k € | -107.5% | -1,7 k € | +97.7% | -72,4 k € | -308.9% | 34,6 k € | -38.8% | 56,7 k € | +306.0% | 14,0 k € | -31.4% | 20,4 k € | +100.2% | 10,2 k € | +123.5% | -43,2 k € | +68.2% | -136,1 k € | |
| Equity | -26,0 k € | +74.5% | -102,1 k € | -3.5% | -98,6 k € | -1.7% | -96,9 k € | -294.4% | -24,6 k € | +58.5% | -59,2 k € | +48.9% | -115,9 k € | +10.7% | -129,8 k € | +13.6% | -150,2 k € | +6.3% | -160,4 k € | -36.9% | -117,1 k € | |
| Total assets | 81,8 k € | -44.6% | 147,6 k € | -47.0% | 278,4 k € | +76.8% | 157,5 k € | -9.5% | 174,0 k € | -13.2% | 200,5 k € | +1120.0% | 16,4 k € | +20.4% | 13,6 k € | +26.9% | 10,8 k € | -37.3% | 17,1 k € | -43.0% | 30,1 k € | |
| Cash | 264,9 € | -99.4% | 42,1 k € | +394.6% | 8,5 k € | +3.8% | 8,2 k € | +95.8% | 4,2 k € | -39.5% | 6,9 k € | -19.4% | 8,6 k € | -3.2% | 8,9 k € | +130.9% | 3,8 k € | -29.9% | 5,5 k € | +164.4% | 2,1 k € | |
| Debts | 107,8 k € | -46.4% | 201,1 k € | -20.7% | 253,4 k € | +121.1% | 114,6 k € | -42.3% | 198,6 k € | -23.5% | 259,7 k € | +96.3% | 132,3 k € | -3.4% | 137,0 k € | -14.9% | 161,0 k € | -8.6% | 176,0 k € | +19.5% | 147,2 k € | |
Private company with limited liability · Scherpenheuvel-Zichem · incorporated on 24/12/1998
Private company with limited liability with a balanced profile. Cash position declining (-99.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
HUISARTSENPRAKTIJK DR. DE WIJS - DR. GEYS is a Private company with limited liability incorporated in 1998. Its main activity is: General medical practice activities. Its registered office is in Scherpenheuvel-Zichem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette